Clinical trial
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in…
NCT00499395 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00499395 |
|---|---|
| Title | Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer |
| Official title | Detection of Residual Colorectal Liver Metastases Within 24 Hours After RFA With 18-F FDG PET |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Procedure |
| Interventions | positron emission tomography, radiofrequency ablation |
| Enrollment | 4 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 11, 2007 |
| Last update posted | Apr 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: